| abstract |
The present invention relates to the use of the derivatives of general formula I <IMAGE> (I) in which: n can have the values 1 to 6, and R represents a hydrogen atom, a halogen, a C1 to C4 lower alkyl radical, a nitro radical, a hydroxyl radical, an oxo radical, a C1 to C4 lower alkoxy radical, a cyano radical, a C1 to C4 lower alkyl carboxylate radical, an aryl or substituted aryl radical, or an amino or substituted amino radical of formula <IMAGE> in which R1 and R2, which may be identical or different, represent a hydrogen atom, an alkyl radical, an aryl radical, an alkylcarboxy radical, an arylcarboxy radical, an alkylsulphonyl radical or an arylsulphonyl radical, the alkyl fragments of these radicals containing from 1 to 4 carbon atoms for the manufacture of medicinal products intended for the treatment of disorders associated with the withdrawal syndrome induced by the discontinuation of benzodiazepines such as diazepam, cocaine, alcohol and/or nicotine. |